Does the neutrophil-to-lymphocyte ratio predict progression-free survival in metastatic cervical cancer patients?
For patients with metastatic or recurrent cervical cancer, doctors often look for ways to predict how well immunotherapy will work. One simple blood test measure, the neutrophil-to-lymphocyte ratio (NLR), helps forecast disease progression. Research shows that a lower NLR before starting treatment is linked to longer survival times, whereas a higher NLR signals a greater risk of the cancer growing or spreading again sooner.
What the research says
Studies analyzing blood samples from patients treated with immune checkpoint inhibitors found that the combined neutrophil-to-lymphocyte ratio is an independent predictor of progression-free survival. Patients in the 'poor' group based on this ratio faced a notably higher risk of disease progression compared to those in the 'good' group 24.
Specific data indicates that a pre-treatment NLR of 3.91 or lower was associated with significantly extended progression-free survival and overall survival. In contrast, patients with an NLR of 3.91 or higher had shorter survival times and lower response rates to the therapy 6.
Another study identified a cut-off value of 5.33 for the NLR. Patients with a ratio at or above this level had a much lower objective response rate to treatment compared to those with lower ratios. High NLR was also linked to decreased survival outcomes in patients receiving combination immunotherapy 5.
These findings suggest that measuring NLR before starting immunotherapy can help clinicians identify which patients are likely to benefit most from these drugs and which might need alternative treatment plans sooner.
What to ask your doctor
- What is my current neutrophil-to-lymphocyte ratio before starting immunotherapy?
- Does my NLR level suggest I might respond better to immunotherapy or a different treatment?
- How might my blood test results change my treatment plan for metastatic cervical cancer?
- Are there other biomarkers besides NLR that my doctor uses to predict my response to treatment?
This question is drawn from common patient questions about OB/GYN & Women's Health and answered using cited medical research. We do not provide individualized advice.